🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great talk yesterday by our dear PhD fellow Marc Armengol explaining the main outcomes and perspectives of the #DLBCL #3dmodeling work package of the Proteoblood project coordinated by Josep Carreras Leukaemia Research Institute (IJC) Roué Lab 👏

El Josep Carreras Leukaemia Research Institute (IJC) ha sido seleccionado por National Cancer Institute con el apoyo del Ministerio de Ministerio de Ciencia, Innovación y Universidades para el proyecto #ProteomaDelCáncer, una iniciativa internacional para el estudio de los tumores malignos. Lee aquí la notícia➡️ carrerasresearch.org/es/el-institut…

Ens fa il·lusió haver rebut al Josep Carreras Leukaemia Research Institute (IJC) alumnes de 4art ESO de l’escola Mare de Deu de la Mercè Mercedàries St Feliu de Sant Feliu de Llobregat, els nostres investigadors Gaël Roué i @belverlab els han fet participar de la vida del centre dins el programa #Insticiència

🤝The Spanish-French project Proteoblood coordinated by our Group Leader @GaelRoueBCN, from the Lymphoma Translational lab (Roué Lab). Its aim is to study hemostatic proteins in two prevalent types of #leukemia and #lymphoma and develop personalized treatments to cure them.

➕We're glad to receive today in our Institute researchers from the centers involved in Proteoblood to hold the Closure Meeting of the project. Cooperation is key in research and this project is an example of it!👏

Enormously satisfied to have been able to hold this 2-days meeting in person at Josep Carreras Leukaemia Research Institute (IJC) , sharing scientific discussions and laboratory practices with our extraordinary partners and friends from the Proteoblood consortium.

Nuestro coordinador el Gaël Roué @institutjosepcarrera resume en que ha consistido el trabajo de nuestro consorcio. El objetivo es estudiar las alteraciones proteicas en dos tipos prevalentes de cánceres de la🩸, #leucemia y #linfoma y desarrollar tratamientos personalizados

Notre coordinateur Gaël Roué de @institutjosepcarreras résume en quoi a consisté le travail de notre consortium L'objectif est d'étudier les altérations protéiques dans deux types de cancers du 🩸 la #leucémie et le #lymphome, et de développer des traitements personnalisés

Chers amis du consortium CEBPAML j'ai porté au mieux cette nouvelle histoire doublée d'une collaboration incroyable ce matin à la session Molecular Hematopoiesis de l' #EHA. Enormes mercis à Marie Sabatier, Rudy Birsen et Jérome Tamburini de l'#UNIGeneva de me permettre tout çà!

Ahir #PhDDayCanRuti Can Ruti PhD Committee amb els investigadors predoctorals de tot el campus #Badalona Josep Carreras Leukaemia Research Institute (IJC) IGTP IrsiCaixa Hosp. Germans Trias, força pedrera!

Eager to learn about the latest achievements of the 2014-2020 #poctefa program, in which we participate through the Proteoblood project Roué Lab Josep Carreras Leukaemia Research Institute (IJC) European Union #Bilbao